Free Trial

HCW Biologics (HCWB) Short Interest Ratio & Short Volume

HCW Biologics logo
$9.18 +0.61 (+7.12%)
As of 04:00 PM Eastern

HCW Biologics Short Interest Data

HCW Biologics (HCWB) has a short interest of 6,900 shares, representing 1.03% of the float (the number of shares available for trading by the public). This marks a -22.47% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 257,966 shares to cover all short positions.

Current Short Interest
6,900 shares
Previous Short Interest
8,900 shares
Change Vs. Previous Month
-22.47%
Dollar Volume Sold Short
$55,614.00
Short Interest Ratio
0.5 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
1,439,000 shares
Float Size
667,700 shares
Short Percent of Float
1.03%
Today's Trading Volume
224,826 shares
Average Trading Volume
257,966 shares
Today's Volume Vs. Average
87%
Short Selling HCW Biologics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for HCW Biologics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

HCWB Short Interest Over Time

HCWB Days to Cover Over Time

HCWB Percentage of Float Shorted Over Time

HCW Biologics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20256,900 shares $55,614.00 -22.5%1.0%0.5 $8.06
4/15/20258,900 shares $74,315.00 -97.7%1.3%0.1 $8.35
3/31/2025390,900 shares $4.41 million -13.2%1.5%0.1 $11.28
3/15/2025450,200 shares $153,068.00 -17.2%1.7%0.1 $0.34
2/28/2025543,700 shares $206,714.74 -34.9%2.1%0.1 $0.38
2/15/2025835,500 shares $334,283.55 +905.4%3.6%0.1 $0.40
1/31/202583,100 shares $23,118.42 +50.8%0.4%0 $0.28
1/15/202555,100 shares $19,780.90 -57.9%0.3%0 $0.36
12/31/2024131,000 shares $58,439.10 -43.6%0.7%0 $0.45
12/15/2024232,100 shares $82,859.70 +80.1%1.2%0 $0.36
11/30/2024128,900 shares $60,840.80 -10.9%0.7%0 $0.47
11/15/2024144,700 shares $42,628.62 +1,686.4%0.7%0 $0.29
10/31/20248,100 shares $3,491.10 -67.5%0.0%0.3 $0.43
10/15/202424,900 shares $13,944.00 -11.4%0.1%1.1 $0.56
9/30/202428,100 shares $15,157.14 +119.5%0.2%1.4 $0.54
9/15/202412,800 shares $7,808.00 +212.2%0.1%0.5 $0.61
8/31/20244,100 shares $1,890.10 -65.0%0.0%0.2 $0.46
8/15/202411,700 shares $5,861.70 +69.6%0.1%0.7 $0.50
7/31/20246,900 shares $4,165.53 -4.2%0.0%0.3 $0.60
7/15/20247,200 shares $5,040.00 -21.7%0.0%0.4 $0.70
6/30/20249,200 shares $5,952.40 +70.4%0.1%0.4 $0.65
6/15/20245,400 shares $6,048.00 +350.0%0.0%0.3 $1.12
5/31/20241,200 shares $1,308.00 -7.7%0.0%0.1 $1.09
5/15/20241,300 shares $1,508.00 -84.9%0.0%0.1 $1.16
4/30/20248,600 shares $12,040.00 +13.2%0.1%0.5 $1.40
4/15/20247,600 shares $12,312.00 -52.2%0.1%0.5 $1.62
3/31/202415,900 shares $27,825.00 -27.7%0.1%1 $1.75
3/15/202422,000 shares $33,660.00 -8.3%0.1%1.3 $1.53
2/29/202424,000 shares $35,280.00 +445.5%0.2%1.7 $1.47
2/15/20244,400 shares $5,030.08 +2.3%0.0%0.4 $1.14
1/31/20244,300 shares $4,945.00 -39.4%0.0%0.2 $1.15
1/15/20247,100 shares $8,378.00 -4.1%0.0%0.4 $1.18
12/31/20237,400 shares $9,065.00 -38.8%0.0%0.4 $1.23
12/15/202312,100 shares $13,431.00 -40.7%0.1%0.8 $1.11
11/30/202320,400 shares $22,032.00 -4.7%0.1%1.4 $1.08
11/15/202321,400 shares $19,688.00 +170.9%0.1%1.6 $0.92
10/31/20237,900 shares $13,272.00 -16.8%0.0%0.6 $1.68
10/15/20239,500 shares $17,290.00 -10.4%0.1%1.3 $1.82
9/30/202310,600 shares $20,140.00 -53.1%0.1%1.3 $1.90
9/15/202322,600 shares $45,426.00 +5.6%0.1%2.5 $2.01
Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)

So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.

🎯 Click here to watch the video and get the free ticker XGPT just flagged.
8/31/202321,400 shares $38,734.00 -14.4%0.1%1.9 $1.81
8/15/202325,000 shares $52,000.00 +7.8%0.1%1.4 $2.08
7/31/202323,200 shares $47,328.00 -13.4%0.1%1.2 $2.04
7/15/202326,800 shares $56,816.00 -23.7%0.2%1.4 $2.12
6/30/202335,100 shares $76,167.00 +44.4%0.2%1.8 $2.17
6/15/202324,300 shares $51,759.00 +86.9%0.1%1.2 $2.13
5/31/202313,000 shares $19,110.00 -13.3%0.1%0.7 $1.47
5/15/202315,000 shares $22,051.50 -45.3%0.1%1 $1.47
4/30/202327,400 shares $39,146.38 -0.7%0.2%1.8 $1.43
4/15/202327,600 shares $41,400.00 +10.8%0.2%1.5 $1.50
3/31/202324,900 shares $34,884.90 +11.7%0.1%1.2 $1.40
3/15/202322,300 shares $30,105.00 -20.6%0.1%1 $1.35
2/28/202328,100 shares $50,580.00 +53.6%0.2%1.3 $1.80
2/15/202318,300 shares $34,587.00 +140.8%0.1%0.8 $1.89
1/31/20237,600 shares $14,744.00 -68.3%0.0%0.4 $1.94
1/15/202324,000 shares $51,600.00 +31.2%0.2%1.2 $2.15
12/30/202218,300 shares $35,040.84 +19.6%0.1%1.1 $1.91
12/15/202215,300 shares $30,600.00 -41.6%0.1%0.8 $2.00
11/30/202226,200 shares $55,302.96 +84.5%0.2%1.2 $2.11
11/15/202214,200 shares $31,240.00 +23.5%0.1%0.6 $2.20
10/31/202211,500 shares $25,760.00 -45.2%0.1%0.5 $2.24
10/15/202221,000 shares $46,830.00 -58.7%0.1%0.9 $2.23
9/30/202250,900 shares $116,561.00 +216.2%0.3%2.4 $2.29
9/15/202216,100 shares $39,284.00 +35.3%0.1%0.9 $2.44
8/31/202211,900 shares $30,542.54 -7.8%0.1%0.7 $2.57
8/15/202212,900 shares $28,767.00 -30.7%0.1%1 $2.23
7/31/202218,600 shares $44,454.00 +78.9%0.1%1.4 $2.39
7/15/202210,400 shares $24,232.00 -38.1%0.1%0.8 $2.33
6/30/202216,800 shares $36,960.00 +24.4%0.1%0.9 $2.20
6/15/202213,500 shares $32,265.00 -9.4%0.1%0.5 $2.39
5/31/202214,900 shares $30,992.00 -54.6%0.1%0.5 $2.08
5/15/202232,800 shares $64,616.00 +9.0%0.2%1.1 $1.97
4/30/202230,100 shares $70,434.00 -32.5%0.2%0.9 $2.34
4/15/202244,600 shares $121,312.00 -3.5%0.3%0.9 $2.72
3/31/202246,200 shares $126,126.00 -11.0%0.3%0.7 $2.73
3/15/202251,900 shares $106,914.00 +19.6%0.4%0.6 $2.06
2/28/202243,400 shares $95,046.00 -32.4%0.3%0.4 $2.19
2/15/202264,200 shares $150,870.00 -18.5%0.5%0.6 $2.35
1/31/202278,800 shares $168,632.00 -39.3%0.6%0.5 $2.14
1/15/2022129,800 shares $288,156.00 +5.3%1.1%0 $2.22
12/31/2021123,300 shares $286,056.00 +35.5%1.0%0 $2.32
12/15/202191,000 shares $249,340.00 -3.1%0.7%0 $2.74
11/30/202193,900 shares $269,493.00 -0.2%0.8%0 $2.87
11/15/202194,100 shares $278,536.00 -39.5%0.8%0 $2.96
10/29/2021155,400 shares $694,638.00 +60.0%1.3%0.1 $4.47
10/15/202197,100 shares $254,402.00 No Change0.8%0.6 $2.62
9/30/202197,100 shares $309,749.00 +13.0%0.8%0.7 $3.19
9/15/202185,900 shares $325,561.00 +30.2%0.7%0.6 $3.79
8/31/202166,000 shares $262,020.00 +1,366.7%0.8%0.4 $3.97
8/13/20214,500 shares $23,040.00 No Change0.1%0 $5.12
Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)

So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.

🎯 Click here to watch the video and get the free ticker XGPT just flagged.

HCWB Short Interest - Frequently Asked Questions

What is HCW Biologics' current short interest?

Short interest is the volume of HCW Biologics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 6,900 shares of HCWB short. 1.03% of HCW Biologics' shares are currently sold short. Learn More on HCW Biologics' current short interest.

What is a good short interest percentage for HCW Biologics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.03% of HCW Biologics' floating shares are currently sold short.

Is HCW Biologics' short interest increasing or decreasing?

HCW Biologics saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 6,900 shares, a decline of 22.5% from the previous total of 8,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is HCW Biologics' float size?

HCW Biologics currently has issued a total of 1,123,000 shares. Some of HCW Biologics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. HCW Biologics currently has a public float of 667,700 shares.

How does HCW Biologics' short interest compare to its competitors?

1.03% of HCW Biologics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to HCW Biologics: ALX Oncology Holdings Inc. (17.78%), Pulmatrix, Inc. (0.65%), ABVC BioPharma, Inc. (2.18%), KALA BIO, Inc. (7.62%), Longeveron Inc. (4.50%), Annovis Bio, Inc. (13.70%), Sol-Gel Technologies Ltd. (1.80%), Elevation Oncology, Inc. (6.95%), BioVie Inc. (5.76%), Mannatech, Incorporated (0.78%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short HCW Biologics stock?

Short selling HCWB is an investing strategy that aims to generate trading profit from HCW Biologics as its price is falling. HCWB shares are trading up $0.61 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against HCW Biologics?

A short squeeze for HCW Biologics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HCWB, which in turn drives the price of the stock up even further.

How often is HCW Biologics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HCWB, twice per month. The most recent reporting period available is April, 30 2025.




This page (NASDAQ:HCWB) was last updated on 5/20/2025 by MarketBeat.com Staff
From Our Partners